286 related articles for article (PubMed ID: 29421015)
1. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study.
Bagai A; Goodman SG; Cantor WJ; Vicaut E; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Merkely B; Storey RF; Ten Berg JM; Zeymer U; Diallo A; Hamm CW; Tsatsaris A; El Khoury J; Van't Hof AW; Montalescot G
Am Heart J; 2018 Feb; 196():56-64. PubMed ID: 29421015
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW;
JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907
[TBL] [Abstract][Full Text] [Related]
3. Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility.
Lupi A; Schaffer A; Lazzero M; Tessitori M; De Martino L; Rognoni A; Bongo AS; Porto I
Cardiovasc Revasc Med; 2016 Dec; 17(8):528-534. PubMed ID: 27666002
[TBL] [Abstract][Full Text] [Related]
4. Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction: Findings from the ATLANTIC trial.
Kilic S; Fabris E; Van't Hof AWJ; Hamm CW; Lapostolle F; Lassen JF; Tsatsaris A; Diallo A; Vicaut E; Montalescot G;
Am Heart J; 2018 Feb; 196():1-8. PubMed ID: 29421001
[TBL] [Abstract][Full Text] [Related]
5. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
[TBL] [Abstract][Full Text] [Related]
6. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.
Fabris E; van 't Hof A; Hamm CW; Lapostolle F; Lassen JF; Goodman SG; Ten Berg JM; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Cantor WJ; Tsatsaris A; Kerneis M; Diallo A; Vicaut E; Montalescot G
Eur Heart J Acute Cardiovasc Care; 2019 Apr; 8(3):208-217. PubMed ID: 28841028
[TBL] [Abstract][Full Text] [Related]
8. Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
Fabris E; Van't Hof A; Hamm CW; Lapostolle F; Lassen JF; Goodman SG; Ten Berg JM; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Cantor WJ; Kerneis M; Diallo A; Vicaut E; Montalescot G;
Catheter Cardiovasc Interv; 2019 Jun; 93(7):E369-E377. PubMed ID: 30302940
[TBL] [Abstract][Full Text] [Related]
9. Effect of Pre-Hospital Ticagrelor in Primary Percutaneous Coronary Intervention on Patients with ST-Segment Elevation Myocardial Infarction: A systematic review and meta-analysis.
Wang H; Pang X; Yang J; Shao J; Zhang J; Wang L; Mou H
J Pak Med Assoc; 2019 Sep; 69(9):1344-1348. PubMed ID: 31511722
[TBL] [Abstract][Full Text] [Related]
10. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
Lapostolle F; Van't Hof AW; Hamm CW; Stibbe O; Ecollan P; Collet JP; Silvain J; Lassen JF; Heutz WMJM; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Ten Berg J; Zeymer U; Licour M; Tsatsaris A; Montalescot G;
Am J Cardiovasc Drugs; 2019 Apr; 19(2):173-183. PubMed ID: 30353444
[TBL] [Abstract][Full Text] [Related]
11. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
[TBL] [Abstract][Full Text] [Related]
12. Prehospital ticagrelor in ST-segment elevation myocardial infarction.
Montalescot G; van 't Hof AW; Lapostolle F; Silvain J; Lassen JF; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Stibbe O; Ecollan P; Heutz WM; Swahn E; Collet JP; Willems FF; Baradat C; Licour M; Tsatsaris A; Vicaut E; Hamm CW;
N Engl J Med; 2014 Sep; 371(11):1016-27. PubMed ID: 25175921
[TBL] [Abstract][Full Text] [Related]
13. Prehospital Prasugrel Versus Ticagrelor in Real-World Patients With ST-Elevation Myocardial Infarction Referred for Primary PCI: Procedural and 30-Day Outcomes.
Vos NS; Amoroso G; Vink MA; Maarse M; Adams R; Herrman JR; Patterson MS; van der Schaaf RJ; Slagboom T; de Winter RJ
J Invasive Cardiol; 2018 Dec; 30(12):431-436. PubMed ID: 30318484
[TBL] [Abstract][Full Text] [Related]
14. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
Kahlon TS; Barn K; Akram MM; Blankenship JC; Bower-Stout C; Carey DJ; Sun H; Tompkins Weber K; Skelding KA; Scott TD; Green SM; Berger PB
Catheter Cardiovasc Interv; 2017 Feb; 89(2):245-251. PubMed ID: 27142567
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
17. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study.
Silvain J; Storey RF; Cayla G; Esteve JB; Dillinger JG; Rousseau H; Tsatsaris A; Baradat C; Salhi N; Hamm CW; Lapostolle F; Lassen JF; Collet JP; Ten Berg JM; Van't Hof AW; Montalescot G
Thromb Haemost; 2016 Aug; 116(2):369-78. PubMed ID: 27196998
[TBL] [Abstract][Full Text] [Related]
18. Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population.
Cayla G; Lapostolle F; Ecollan P; Stibbe O; Benezet JF; Henry P; Hammett CJ; Lassen JF; Storey RF; Ten Berg JM; Hamm CW; Van't Hof AW; Montalescot G;
Int J Cardiol; 2017 Oct; 244():49-53. PubMed ID: 28622941
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with P2Y12 inhibitors and outcome in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Gach O; Nyssen A; Pirlet C; Magne J; Oury C; Lancellotti P
J Cardiovasc Med (Hagerstown); 2018 May; 19(5):234-239. PubMed ID: 29528868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
